Arnica montana 6x homeopathic tablets

BackgroundThe clinical benefits of homeopathic preparations (HPs) used in anthroposophic medicine and homeopathy remain a topic of debate. Systematic reviews (SRs), with or without meta-analyses (MAs), that assess the literature in line with scientific standards and account for the complex nature of these interventions are lacking for many health conditions. This project aims to conduct SRs to evaluate the efficacy, effectiveness, and safety of HPs for selected patient populations, using a pluralistic approach that considers internal and model validity.MethodsThis protocol follows PRISMA-P. A comprehensive literature search will include the HOMIS database, MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, AMED, LILACS, topic-specific sources, citation indices, trial registers, and grey literature, including preprint servers. Eligible studies will have a prospective, longitudinal design and include randomized controlled trials and non-randomized comparative studies published in various languages, evaluating HP interventions for efficacy, effectiveness, and/or safety in health conditions preselected through expert consensus. All patient types, interventions, co-interventions, therapeutic goals, and comparison groups will be eligible. Research questions and outcomes will be developed with consideration of the patient perspective. Each SR will be conducted by a multidisciplinary team, supported by an advisory group. Risk of bias will be assessed using ROB-2 and ROBINS-I. Model validity and the efficacy-effectiveness spectrum will be evaluated using MVHT and RITES. Intervention complexity will be analyzed with an adapted iCAT_SR. Where meta-analysis is not feasible, a narrative synthesis following SWiM will be conducted; otherwise, quantitative synthesis will be performed. Certainty of evidence will be assessed using GRADE.DiscussionThis series of SRs and MAs will investigate the effects of HPs as complex interventions in healthcare and aims to establish an evidence base regarding their efficacy, effectiveness, and safety. By integrating assessments of internal and model validity and potential effect modifiers, the reviews aim to provide a more comprehensive understanding of the conditions under which HPs may yield clinical benefits. In addition, the project may identify research gaps and methodological shortcomings to inform future studies.Systematic review registrationPROSPERO CRD420251017029.

Abstract licence: CC BY

The pharmaceutical industry has been primarily focused on developing synthetic drugs to address orofacial pain (OFP)-related conditions. There is limited knowledge regarding the efficacy of the use of herbal extracts in treating OFP. A systematic review and a meta-analysis of 62 randomized controlled trials assessing the analgesic effects of herbal extracts on pain intensity in various orofacial conditions was conducted. The intervention comprised the use of herbal extracts compared with a placebo and/or standard treatment. The primary outcome was pain intensity assessed before and after the intervention. The pain scores were compared with the baseline scores in each treatment. When compared with standard therapy, the pooled results of the patients who received herbal extracts revealed lower pain intensity in periodontal pain (MD = -0.92[-6.69, 4.85]), oral surgery pain (MD = 18.80[8.80, 28.79]), oral neuropathic pain (MD = 20.34[6.16, 34.52]), endodontic pain (MD = -8.04[-11.72, -4.37]), oral mucosal pain (MD = 8.74[2.76, 14.73]), and temporomandibular pain (MD = 30.94[6.04, 55.83]). The findings indicated a pain-attenuating effect of herbal extracts such as cannabis, turmeric, capsaicin, licorice, ginger, chamomile, clove, Hypericum perforatum, and Arnica montana. These findings revindicate that herbal extracts may be valuable alternatives to traditional pain medications and promising source for the development of new active ingredients for pharmaceuticals.

Abstract licence: CC BY-NC-ND

Background: Homeopathy remains a controversial therapeutic modality with ongoing debates about its clinical effectiveness. Recent years have seen increased efforts to standardize research methodology and improve evidence quality. Objective: To provide a comprehensive overview of evidence-based homeopathy through systematic analysis of recent meta-analyses and systematic reviews published between 2020-2025. Methods: We conducted a comprehensive literature search across multiple databases (SciSpace, PubMed, Google Scholar) focusing on meta-analyses and systematic reviews of homeopathic interventions published from 2020 onwards. Studies were analyzed for methodological quality, clinical effectiveness, safety profiles, and areas of ongoing controversy. Results: Analysis of 240 studies revealed heterogeneous, generally low-certainty evidence. Recent meta-analyses show occasional small pooled effects for specific preparations (e.g., Arnica montana postoperative: Hedges' g ≈ 0.18, 95% CI −0.007 to 0.373), but findings are limited by small sample sizes, methodological heterogeneity, and high risk of bias in primary studies. New methodological frameworks (Sum-HomIS, CATHIS) have been developed to standardize research approaches and improve evidence quality. Conclusions: Contemporary evidence indicates occasional small effects for specific homeopathic preparations but persistent methodological limitations that constrain clinical inference. The field requires adherence to harmonized methodological recommendations, improved trial conduct, and adequately powered comparative effectiveness studies.

Abstract licence: CC BY

Rheumatoid arthritis (RA) is a chronic, multisystem autoimmune disorder characterized by inflammation of the synovial joints, leading to pain, swelling, stiffness, and progressive joint damage. Conventional treatments, including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologics, are effective but often associated with adverse effects such as gastrointestinal bleeding, hepatotoxicity, and increased infection risk. In this context, homeopathy has emerged as a complementary and alternative medicine (CAM) approach for managing RA. This review explores the mechanisms of action of homeopathic drugs in RA, focusing on immunomodulation, anti-inflammatory effects, and cytokine regulation. Preclinical studies demonstrate that remedies like Arnica montana, Ruta graveolens ,and Guaiacum officinale exhibit significant anti-inflammatory and antioxidant properties by modulating immune cells, reducing pro-inflammatory cytokines, and mitigating oxidative stress. Clinical evidence, though limited, suggests potential benefits of homeopathic drugs in improving symptoms, reducing inflammation, and enhancing quality of life. While these findings highlight the therapeutic potential of homeopathy in RA, further large-scale, randomized controlled trials are needed to validate its efficacy and establish its role as a complementary treatment.

Abstract licence: CC BY